
German laws, European VBCs, and trends in China, Brazil, and Saudi Arabia are changing the way global market access works.

German laws, European VBCs, and trends in China, Brazil, and Saudi Arabia are changing the way global market access works.

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca discusses how the Medical Affairs role will become more strategic and effective with data.

Kevin Hagan, president and CEO of the PAN Foundation, spoke to PharmExec about the recent IRA changes that impact Medicare, as well as the Foundation's near-term goals.

How to build a modular content system to optimize content creation and delivery, Using Al-powered engines that know your HCP's viewing behavior, using discomfort as an advantage and much more.

Kevin Hagan, president and CEO of the PAN Foundation, spoke to PharmExec about the recent IRA changes to Medicare and how it positively effects patients.

How media consumption is evolving and modifying digital and social strategies to best capture the behavioral changes of HCPs towards digital platforms.